Soluble Urokinase Receptor and Liver Disease
Changli Wei, Ke Zhu, Jochen Reiser – 20 December 2019
Reply
Myung Ji Goh, Seonwoo Kim, Sook Young Woo, Dong Hyun Sinn – 20 December 2019
Thrombocytopenia in Cirrhosis: A Review of Pathophysiology and Management Options
Andrew H. Moore – 20 December 2019
Treatment of Dyslipidemia in Common Liver Diseases
Elizabeth K. Speliotes, Maya Balakrishnan, Lawrence S. Friedman, Kathleen E. Corey – 20 December 2019
Endoscopic Ultrasound/Fine Needle Aspiration Is Effective for Lymph Node Staging in Patients With Cholangiocarcinoma
Thomas Malikowski, Michael J. Levy, Ferga C. Gleeson, Andrew C. Storm, Eric J. Vargas, Mark D. Topazian, Barham K. Abu Dayyeh, Prasad G. Iyer, Elizabeth Rajan, Gregory J. Gores, Lewis R. Roberts, Vinay Chandrasekhara – 20 December 2019
Moesin, an Ezrin/Radixin/Moesin Family Member, Regulates Hepatic Fibrosis
Serhan Karvar, Ephraim A. Ansa‐Addo, Jo Suda, Shweta Singh, Lixin Zhu, Zihai Li, Don C. Rockey – 20 December 2019
Correction
20 December 2019
Causes of Sarcopenia in Liver Cirrhosis
Monica Bojko – 20 December 2019
Acute‐on‐Chronic Liver Failure: A Distinct Clinical Syndrome That Has Reclassified Cirrhosis
Giovanni Perricone, Rajiv Jalan – 20 December 2019
Highly Sensitive Circulating MicroRNA Panel for Accurate Detection of Hepatocellular Carcinoma in Patients With Liver Disease
Yusuke Yamamoto, Shunsuke Kondo, Juntaro Matsuzaki, Minoru Esaki, Takuji Okusaka, Kazuaki Shimada, Yoshiki Murakami, Masaru Enomoto, Akihiro Tamori, Ken Kato, Yoshiaki Aoki, Satoko Takizawa, Hiromi Sakamoto, Shumpei Niida, Fumitaka Takeshita, Takahiro Ochiya – 19 December 2019 – Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer deaths worldwide. The high mortality rate in HCC is largely due to the difficulty of early detection.